Bristol-Myers Squibb
BMY
$49.14
Share price
0.43%
Change (1 day)
-30.34%
Change (1 year)
Categories
EPS for Bristol-Myers Squibb (BMY)
EPS in 2023 (TTM): $3.97
According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is $3.97. In 2022 the company made an earnings per share (EPS) of $2.98 a decrease over its 2021 EPS that were of $3.17.
EPS history for Bristol-Myers Squibb from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.97 | 33.22% |
| 2022 | $2.98 | -6.04% |
| 2021 | $3.17 | -179.29% |
| 2020 | -$4.00 | -281.37% |
| 2019 | $2.21 | -27.21% |
| 2018 | $3.03 | 388.71% |
| 2017 | $0.62 | -76.78% |
| 2016 | $2.67 | 175.26% |
| 2015 | $0.97 | -19.83% |
| 2014 | $1.21 | -22.44% |
| 2013 | $1.56 | 34.48% |
| 2012 | $1.16 | -47.03% |
| 2011 | $2.19 | 21.67% |
| 2010 | $1.80 | -66.36% |
| 2009 | $5.35 | 104.2% |
| 2008 | $2.62 | 140.37% |
| 2007 | $1.09 | 36.25% |
| 2006 | $0.80 | -47.37% |
| 2005 | $1.52 | 23.58% |
| 2004 | $1.23 | -23.6% |
| 2003 | $1.61 | 50.47% |
| 2002 | $1.07 | 1.9% |
| 2001 | $1.05 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 254.79% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -5.79% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -53.15% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -7.29% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 36.76% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 256.42% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | -19.89% | 🇫🇷 France |
 Biogen BIIB | $18.46 | 364.99% | 🇺🇸 USA |
 Merck MRK | $1.82 | -54.11% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -50.00% | 🇬🇧 UK |